Transfection and in vitro expression of human microdystrophin gene in rat mesenchymal stem cells.
- Author:
Shu-hui WANG
1
;
Cheng ZHANG
;
Song-lin CHEN
;
Mei-juan YU
;
Ya-ni ZHANG
;
Mei-shan LI
;
Fu XIONG
;
Yan-chang SHANG
;
Shan-wei FENG
;
Ben-chang SHEN
Author Information
- Publication Type:Journal Article
- MeSH: Animals; Base Sequence; Cells, Cultured; Dystrophin; biosynthesis; genetics; Fluorescent Antibody Technique, Indirect; Gene Expression; Humans; Mesenchymal Stromal Cells; cytology; metabolism; Molecular Sequence Data; Peptide Fragments; biosynthesis; genetics; Plasmids; genetics; RNA, Messenger; biosynthesis; genetics; metabolism; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transfection
- From: Journal of Southern Medical University 2006;26(3):261-265
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo construct the eukaryotic expression vector of human microdystrophin gene and observe its expression in rat mesenchymal stem cells (rMSCs) in vitro.
METHODSThe plasmid PBSK-MICRO containing human microdystrophin cDNA was digested by restriction endonuclease, and the resultant microdystrophin fragment was inserted into the NotI site of pcDNA3.1(+) to prepare the eukaryotic expression vector-pcDNA3.1(+)/ microdystrophin, which was identified by endonuclease digestion and sequencing. The recombinant plasmid was transfected into rMSCs via lipofectamine, and after G418 selection, the expression of microdystrophin was detected by RT-PCR and indirect immunofluorescence assay.
RESULTSMicrodystrophin gene fragment was correctly inserted into the plasmid pcDNA3.1(+), as conformed by sequencing and digestion with Not I and Hind III. The total mRNA of the transfected rMSCs was extracted and microdystrophin mRNA expression was found in the cells by RT-PCR. Indirect immunofluorescence assay for the protein expression of microdystrophin showed bright red fluorescence in the transfected rMSCs.
CONCLUSIONEukaryotic expression plasmid pcDNA3.1(+)/microdystrophin has been constructed successfully and microdystrophin can be expressed in transfected rMSCs in vitro, which may facilitate further research of Duchenne muscular dystrophy treatment by genetically modified allogeneic stem cell transplantation.